SEMINOMA
Clinical trials for SEMINOMA explained in plain language.
Never miss a new study
Get alerted when new SEMINOMA trials appear
Sign up with your email to follow new studies for SEMINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Robot surgery could spare seminoma patients from chemo side effects
Disease control Recruiting nowThis study tests a robot-assisted surgery to remove lymph nodes in men with stage II seminoma (a type of testicular cancer). The goal is to see if this approach can predict cancer recurrence and allow some patients to avoid chemotherapy and its long-term side effects. About 60 pa…
Matched conditions: SEMINOMA
Phase: PHASE2 • Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Robots and dye could spare testicular cancer patients from unnecessary treatment
Diagnosis Recruiting nowThis study is testing a new, more precise robot-assisted technique that uses a special dye (ICG) to find if testicular cancer has spread to nearby lymph nodes. Current methods often miss small cancer deposits, leading to either under- or overtreatment. The goal is to see if this …
Matched conditions: SEMINOMA
Phase: NA • Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Diagnosis
Last updated May 17, 2026 01:36 UTC
-
Testicular cancer study: which treatment spares quality of life?
Knowledge-focused Recruiting nowThis study follows 160 men with good prognosis metastatic testicular cancer to see if surgery (RPLND) causes fewer side effects than chemotherapy. Participants choose or are assigned to either surgery or 3-4 rounds of chemo. Researchers track quality of life, fatigue, and other o…
Matched conditions: SEMINOMA
Phase: NA • Sponsor: Sahlgrenska University Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 01:45 UTC
-
Doctors test gentler cancer treatments to preserve quality of life
Knowledge-focused Recruiting nowThis study is gathering information from 30 testicular cancer patients in the UK who are receiving either standard treatments or less intensive options. Researchers want to see if patients are willing to join such studies, how different treatments affect cancer outcomes and quali…
Matched conditions: SEMINOMA
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Apr 20, 2026 16:18 UTC